You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2013
|
| DOI | 10.1002/14651858.cd005481.pub3 |
| Pubmed ID | |
| Authors |
Muki S Shey, Eugene J Kongnyuy, Samuel M Alobwede, Charles S Wiysonge |
| Abstract |
UNAIDS estimates that 34 million people are currently living with the human immunodeficiency virus (HIV) worldwide. Currently recommended regimens for initiating HIV treatment consist of either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or ritonavir-boosted protease inhibitor (PI) combined with two nucleoside reverse transcriptase inhibitors (NRTIs). However, there may be some patients for whom NNRTIs and PIs may not be appropriate. This is an update of the review published in the Cochrane Library Issue 3, 2009. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Venezuela, Bolivarian Republic of | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 153 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 14% |
| Student > Master | 20 | 13% |
| Researcher | 18 | 12% |
| Student > Ph. D. Student | 13 | 8% |
| Student > Doctoral Student | 8 | 5% |
| Other | 30 | 19% |
| Unknown | 45 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 31% |
| Psychology | 11 | 7% |
| Nursing and Health Professions | 10 | 6% |
| Social Sciences | 8 | 5% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Other | 24 | 15% |
| Unknown | 49 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2016.
All research outputs
#16,106,935
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#10,216
of 11,499 outputs
Outputs of similar age
#124,272
of 210,450 outputs
Outputs of similar age from Cochrane database of systematic reviews
#170
of 201 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,450 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 201 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.